UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000025747 |
|---|---|
| Receipt number | R000029624 |
| Scientific Title | A randomized controlled trial of gemcitabine hydrochloride plus S-1 combination (GS) therapy and gemcitabine hydrochloride (Gem) therapy alone for patients with pancreatic cancer who are 75 years or older. |
| Date of disclosure of the study information | 2017/02/18 |
| Last modified on | 2019/01/21 09:09:48 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/01/19 16:48:52 | ||
| 2 | Update | 2017/04/21 14:26:25 | Email |
|
| 3 | Update | 2017/07/21 10:57:20 | UMIN ID1 |
|
| 4 | Update | 2017/07/21 11:01:01 | Name of person sending information Name of person sending information Organization Organization Division name Address Address TEL |
|
| 5 | Update | 2019/01/21 09:09:48 | Recruitment status Last follow-up date Date of closure to data entry URL releasing protocol Results |
